SCHEMBL7418006

SCHEMBL7418006

Cc1cc(C)c(S(=O)(=O)NCC(NS(=O)(=O)c2cc(Cl)ccc2Cl)C(=O)NO)c(C)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP7 P09237 4/20 0.47
PSMB5 P28074 1/20 0.44
RAB9A P51151 1/20 0.44
KDM4E B2RXH2 1/20 0.42
MMP9 P14780 2/20 0.41
MMP10 P09238 1/20 0.41
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
MMP1 P03956 1/20 0.40
MMP2 P08253 1/20 0.40
MMP8 P22894 1/20 0.40
MMP13 P45452 1/20 0.40
ALDH1A1 P00352 2/20 0.40
LMNA P02545 2/20 0.40
MAPT P10636 1/20 0.40
HTT P42858 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MAPK1 P28482 1/20 0.39
PSMB8 P28062 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7422957 0.96 MMP7 (0.47) MMP7PSMB5RAB9AKDM4EMMP9
SCHEMBL7418075 0.88 MMP7 (0.55) MMP7PSMB5RAB9AKDM4EMMP9
SCHEMBL7411120 0.86 MMP7 (0.54) MMP7MMP9MMP10
SCHEMBL7416093 0.84 MMP7 (0.52) MMP7PSMB5RAB9AMMP9MMP10
SCHEMBL7413136 0.84 MMP9 (0.53) MMP7RAB9AMMP9MMP10CA1
SCHEMBL7414547 0.84 MMP7 (0.54) MMP7MMP9MMP10CA1CA2
SCHEMBL7415732 0.84 MMP7 (0.56) MMP7PSMB5RAB9AKDM4EMMP9
SCHEMBL7417174 0.82 MMP7 (0.58) MMP7PSMB5RAB9AKDM4EMMP9
SCHEMBL7407679 0.81 MMP7 (0.56) MMP7PSMB5RAB9AMMP9MMP10
SCHEMBL7410656 0.80 MMP7 (0.58) MMP7PSMB5RAB9AMMP9MMP10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218389-B1 FOR THERAPY AND PROPHYLAXIS OF ARTHRITIS, CANCER, CARDIOVASCULAR DISORDERS; SKIN DISORDERS; OCULAR DISORDERS; INFLAMMATION AND GUM DISEASES, MULTIPLE SCLEROSIS, CACHEXIA, PREVENTING LOOSENING OF PROSTHETIC DEVICES THE PROCTER & GAMBLE CO. 2001-04-17 US disclosed
EP-1009737-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 2000-06-21 EP disclosed
WO-1999006340-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 1999-02-11 WO disclosed